Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 42Lung Neoplasms 32Head and Neck Neoplasms 24Glioblastoma 24Squamous Cell Carcinoma of Head and Neck 22Breast Neoplasms 21Lymphoma 17Brain Neoplasms 17Rectal Neoplasms 16Prostatic Neoplasms 15Lymphoma, Non-Hodgkin 14Leukemia, Lymphocytic, Chronic, B-Cell 13Leukemia 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Follicular 11Gliosarcoma 11Esophageal Neoplasms 11Central Nervous System Neoplasms 11Adenocarcinoma Of Esophagus 11Pancreatic Neoplasms 10Melanoma 10Lymphoma, Large B-Cell, Diffuse 10Hodgkin Disease 10Neoplasm Metastasis 9Multiple Myeloma 9Neoplasms, Plasma Cell 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Acute 8Burkitt Lymphoma 8Sarcoma 7

Interventions

Gemcitabine 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2pembrolizumab 1folfirinox 1amatuximab 1Radiotherapy 1Pemetrexed 1Paclitaxel 1PEGPH20 1Oxaliplatin 1Leucovorin 1Fluorouracil 1Cisplatin 1Cetuximab 1Carboplatin 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Pancreatic Ductal × Radiotherapy × Clear all
NCT02243007 2017-05-16

Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer

Massachusetts General Hospital

Phase 2 Terminated
7 enrolled 8 charts
Gastrointestinal

Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡